{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:09:41Z","timestamp":1787314181716,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","award":["04\/2020\/TN"],"award-info":[{"award-number":["04\/2020\/TN"]}],"id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.transproceed.2022.07.009","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T08:44:54Z","timestamp":1662453894000},"page":"2140-2146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Frequencies and Association of CYP3A5 Polymorphism With Tacrolimus Concentration Among Renal Transplant Recipients in Vietnam"],"prefix":"10.1016","volume":"54","author":[{"given":"Nguyen Thanh","family":"Xuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Quang","family":"Hop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Truong Quy","family":"Kien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Quoc","family":"Toan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Viet","family":"Thang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Thanh","family":"Binh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham","family":"Van Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Thi","family":"Minh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Thi","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Xuan","family":"Cuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Huu","family":"Ben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Minh","family":"Phuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Tung","family":"Linh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thuy","family":"Linh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vu Dinh","family":"Dung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Thi Bao","family":"Quyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Thi Thu","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5002-0419","authenticated-orcid":false,"given":"Hoang Xuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.07.009_bib0001","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.mpmed.2019.07.002","article-title":"Renal transplantation","volume":"47","author":"Baker","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0002","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.transproceed.2022.07.009_bib0003","first-page":"S1","article-title":"Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Disease","year":"2009","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0004","article-title":"Optimization of tacrolimus in kidney transplantation: new pharmacokinetic perspectives","volume":"34","author":"Oberbauer","year":"2020","journal-title":"Transplant Rev Orlando Fla"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0005","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/FTD.0b013e318198d092","article-title":"Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference","volume":"31","author":"Wallemacq","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0006","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cca.2011.10.013","article-title":"Pharmacogenetic biomarkers: cytochrome P450 3A5","volume":"413","author":"MacPhee","year":"2012","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0007","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.transproceed.2016.01.001","article-title":"HWM. Effects of CYP3A5 genetic polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients","volume":"48","author":"Mac Guad","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0008","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0010","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.transproceed.2009.01.097","article-title":"Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus","volume":"41","author":"Chen","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0011","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fphar.2020.01142","article-title":"The clinical impact of the C0\/D Ratio and the CYP3A5 genotype on outcome in tacrolimus treated kidney transplant recipients","volume":"11","author":"van Gelder","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0012","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1111\/ajt.15385","article-title":"Tacrolimus troughs and genetic determinants of metabolism in kidney transplant recipients: a comparison of four ancestry groups","volume":"19","author":"Mohamed","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0013","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.transproceed.2010.08.063","article-title":"Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients","volume":"42","author":"Rong","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.transproceed.2005.01.077","article-title":"Genetic polymorphisms of CYP3A5 genes and concentration of the cyclosporine and tacrolimus","volume":"37","author":"Zhao","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.transproceed.2011.11.004","article-title":"Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients","volume":"44","author":"Cho","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0016","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.transproceed.2018.02.032","article-title":"CYP3A5*3 genetic polymorphism and tacrolimus concentration in Myanmar renal transplant patients","volume":"50","author":"Htun","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0017","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00228-008-0573-8","article-title":"Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam","volume":"65","author":"Veiga","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0018","first-page":"721","article-title":"Optimization of initial tacrolimus dose using pharmacogenetic testing","volume":"87","author":"Thervet","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0019","doi-asserted-by":"crossref","first-page":"81285","DOI":"10.18632\/oncotarget.18150","article-title":"Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/1526924819873905","article-title":"Comparison of tacrolimus starting doses based on CYP3A5 phenotype or genotype in kidney transplant recipients","volume":"29","author":"Largeau","year":"2019","journal-title":"Prog Transplant"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0021","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3389\/fphar.2020.01218","article-title":"CYP3A5 gene-guided tacrolimus treatment of living-donor Egyptian kidney transplanted patients","volume":"11","author":"Mendrinou","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0022","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1016\/j.transproceed.2010.06.028","article-title":"Value of CYP3A5 genotyping on determining initial dosages of tacrolimus for Chinese renal transplant recipients","volume":"42","author":"Zhang","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.07.009_bib0023","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/gtmb.2020.0077","article-title":"Tacrolimus starting dose prediction based on genetic polymorphisms and clinical factors in Chinese renal transplant recipients","volume":"24","author":"Wang","year":"2020","journal-title":"Genet Test Mol Biomark"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522005140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522005140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:42:54Z","timestamp":1758577374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522005140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0041134522005140"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.07.009","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequencies and Association of CYP3A5 Polymorphism With Tacrolimus Concentration Among Renal Transplant Recipients in Vietnam","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}